NCT05044819 2026-03-17
Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
Jazz Pharmaceuticals
Phase 4 Active not recruiting
Jazz Pharmaceuticals
M.D. Anderson Cancer Center
Imperial College London
Stanford University
Singlera Genomics Inc.
University of Alabama at Birmingham
University of Alabama at Birmingham
Asan Medical Center